Molecular Mechanisms Underlying Single Nucleotide Polymorphism-Induced Reactivity Decrease in CYP2D6.

Area of Science:

• Biochemistry
• Pharmacogenomics
• Molecular Biology

Background:

• Cytochrome P450 2D6 (CYP2D6) is crucial for drug metabolism.
• Genetic variations (polymorphisms) in CYP2D6 significantly alter drug efficacy and safety.
• A detailed atomistic understanding of poor CYP2D6 activity has been lacking.

Purpose of the Study:

• To elucidate the atomistic mechanisms underlying poor drug metabolism caused by CYP2D6 genetic polymorphisms.
• To identify key structural and functional features essential for optimal CYP2D6 enzyme activity.
• To predict the impact of single nucleotide polymorphisms (SNPs) on CYP2D6 function.

Main Methods:

• Extensive all-atom molecular dynamics simulations were performed on the 20 most common CYP2D6 single nucleotide polymorphisms (SNPs).
• Analysis focused on structural elements including helix rigidity, substrate-binding site interactions, cofactor binding interfaces, and electron transfer pathways.
• Computational predictions were validated by applying identified mechanisms to SNPs with previously unknown functional effects.

Main Results:

• Four primary mechanisms driving poor CYP2D6 metabolism were identified at the atomistic level.
• Key factors include the rigidity of the I-helix, the spatial arrangement of phenylalanines stabilizing substrates, the accessibility of surface residues for cytochrome P450 reductase binding, and the positioning of arginine 132 for heme electron transfer.
• The study successfully predicted potential SNPs associated with poor drug metabolism among those with unknown effects.

Conclusions:

• The identified molecular mechanisms provide a fundamental explanation for reduced CYP2D6 activity due to genetic variations.
• These findings enhance our understanding of pharmacogenomics and personalized medicine.
• The revealed principles may be applicable to understanding the function of other drug-metabolizing cytochrome P450 enzymes.